BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12898644)

  • 41. Analysis of local tissue-specific gene expression in cellular micropatterns.
    Lee JY; Jones C; Zern MA; Revzin A
    Anal Chem; 2006 Dec; 78(24):8305-12. PubMed ID: 17165820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytotoxicity of ginkgolic acid in HepG2 cells and primary rat hepatocytes.
    Liu ZH; Zeng S
    Toxicol Lett; 2009 Jun; 187(3):131-6. PubMed ID: 19429255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
    Schulz C; Kammerer S; Küpper JH
    Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HPLC analysis of lipoproteins in culture medium of hepatoma cells: an in vitro system for screening antihyperlipidemic drugs.
    Itoh M; Abe Y; Iwama Y; Kimura F; Satoh M; Shoji M; Takahashi J; Toshima G; Sasaki H; Hiwatashi K; Hata K
    Biotechnol Lett; 2009 Jul; 31(7):953-7. PubMed ID: 19330486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1.
    Braeuning A; Sanna R; Huelsken J; Schwarz M
    Drug Metab Dispos; 2009 May; 37(5):1138-45. PubMed ID: 19237511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity.
    Ruoß M; Damm G; Vosough M; Ehret L; Grom-Baumgarten C; Petkov M; Naddalin S; Ladurner R; Seehofer D; Nussler A; Sajadian S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of cytochrome P450 enzymes in hepatic organoid reconstructed by rat small hepatocytes.
    Miyamoto S; Hirata K; Sugimoto S; Harada K; Mitaka T
    J Gastroenterol Hepatol; 2005 Jun; 20(6):865-72. PubMed ID: 15946133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of coumarin-induced toxicity between sandwich-cultured primary rat hepatocytes and rats in vivo: a toxicogenomics approach.
    Kienhuis AS; Wortelboer HM; Hoflack JC; Moonen EJ; Kleinjans JC; van Ommen B; van Delft JH; Stierum RH
    Drug Metab Dispos; 2006 Dec; 34(12):2083-90. PubMed ID: 16963487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines.
    Brandon EF; Bosch TM; Deenen MJ; Levink R; van der Wal E; van Meerveld JB; Bijl M; Beijnen JH; Schellens JH; Meijerman I
    Toxicol Appl Pharmacol; 2006 Feb; 211(1):1-10. PubMed ID: 15975613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells.
    Rodríguez-Antona C; Donato MT; Boobis A; Edwards RJ; Watts PS; Castell JV; Gómez-Lechón MJ
    Xenobiotica; 2002 Jun; 32(6):505-20. PubMed ID: 12160483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor.
    Mueller D; Tascher G; Müller-Vieira U; Knobeloch D; Nuessler AK; Zeilinger K; Heinzle E; Noor F
    J Tissue Eng Regen Med; 2011 Aug; 5(8):e207-18. PubMed ID: 21442764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Use of primary cultured hepatocytes for toxicology].
    Kohira T; Nakamura T
    J Toxicol Sci; 1989 Dec; 14 Suppl 3():108-14. PubMed ID: 2639199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative analysis of 3D culture methods on human HepG2 cells.
    Luckert C; Schulz C; Lehmann N; Thomas M; Hofmann U; Hammad S; Hengstler JG; Braeuning A; Lampen A; Hessel S
    Arch Toxicol; 2017 Jan; 91(1):393-406. PubMed ID: 26872951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell lines: a tool for in vitro drug metabolism studies.
    Donato MT; Lahoz A; Castell JV; Gómez-Lechón MJ
    Curr Drug Metab; 2008 Jan; 9(1):1-11. PubMed ID: 18220566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of Matrigel-overlay on constitutive and inducible expression of nine genes encoding drug-metabolizing enzymes in primary human hepatocytes.
    Gross-Steinmeyer K; Stapleton PL; Tracy JH; Bammler TK; Lehman T; Strom SC; Eaton DL
    Xenobiotica; 2005 May; 35(5):419-38. PubMed ID: 16012075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High metabolic function of primary human and porcine hepatocytes in a polyurethane foam/spheroid culture system in plasma from patients with fulminant hepatic failure.
    Yamashita Y; Shimada M; Tsujita E; Shirabe K; Ijima H; Nakazawa K; Sakiyama R; Fukuda J; Funatsu K; Sugimachi K
    Cell Transplant; 2002; 11(4):379-84. PubMed ID: 12162378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of culture duration on gene expression of P450 isoforms, uptake and efflux transporters in primary hepatocytes cultured in the absence and presence of interleukin-6: implications for experimental design for the evaluation of downregulatory effects of biotherapeutics.
    Yang Q; Doshi U; Li N; Li AP
    Curr Drug Metab; 2012 Sep; 13(7):938-46. PubMed ID: 22475270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell lines.
    Kvist AJ; Kanebratt KP; Walentinsson A; Palmgren H; O'Hara M; Björkbom A; Andersson LC; Ahlqvist M; Andersson TB
    Biochem Pharmacol; 2018 Sep; 155():124-140. PubMed ID: 29953844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improvement of HepG2/C3a cell functions in a microfluidic biochip.
    Prot JM; Aninat C; Griscom L; Razan F; Brochot C; Guillouzo CG; Legallais C; Corlu A; Leclerc E
    Biotechnol Bioeng; 2011 Jul; 108(7):1704-15. PubMed ID: 21337338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues.
    Hart SN; Li Y; Nakamoto K; Subileau EA; Steen D; Zhong XB
    Drug Metab Dispos; 2010 Jun; 38(6):988-94. PubMed ID: 20228232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.